Safety and Effectiveness of Elotuzumab in Japanese Patients with Relapsed/Refractory Multiple Myeloma: A Post-marketing Surveillance Study

Conclusion This all-case post-marketing surveillance study showed that ELd had an acceptable tolerability profile and promising clinical activity in Japanese patients with RRMM.PMID:38494720 | DOI:10.2169/internalmedicine.2487-23

Source: Internal Medicine - March 18, 2024 Category: Internal Medicine Authors: Fumiya Kaneko Hiroshi Suzuka Tomoaki Yoshino Ryosuke Hinosugi Source Type: research